Skip to main content

Venture Briefing @UNIGE

Venture Briefing @UNIGE 17 NovembreNov 2023 12:15 - 13:15Salle MR170, UNI MAIL - Bd du Pont-d'Arve 40, 1205 Genève

Venture Briefing with Christina Vallgren, CEO of TERAPET, a Geneva-based CERN MedTech spin-off specialized in cancer therapies, that has developed an innovative platform technology for imaging in nuclear medicine, bringing proton therapy and nuclear imaging to the next level. TERAPET is listed in the TOP100 Swiss Startup Award 2023.


Venture Briefing is an event designed to help students with an intent to pursue entrepreneurship take their first steps towards building a successful company. Experienced entrepreneurs will share their journey bringing their idea to life and will answer all your questions. Startup support programs will be introduced, such as Venture Kick, Innobooster and First Ventures.


More information and registration.


Christina Vallgren, CEO of TERAPET

Organisation: venturelab


Salle MR170, UNI MAIL - Bd du Pont-d'Arve 40, 1205 Genève


Impossible de trouver l'itinéraire !

  • Planifié
  • Invités
  • Assistance
  • Prévision
  • Commentaires

Les données météorologiques sont actuellement pas disponible pour cet emplacement

Bulletin Météorologique

Aujourd'hui stec_replace_today_date



stec_replace_current_temp °stec_replace_current_temp_units

Vent stec_replace_current_wind stec_replace_current_wind_units stec_replace_current_wind_direction

Humidité stec_replace_current_humidity %

Feels like stec_replace_current_feels_like °stec_replace_current_temp_units


Date de fin




Prochaines 24 heures

Propulsé par